Last week, court documents revealed the FDA was requesting the court to schedule a monthly release of the documents over the next 55 years. This suggests the “full transparency” the FDA assured to the American public would not be accomplished until the year 2076.
The FDA was sued soon after it approved the injection for not giving a single page of documentation relating to that ruling beforehand. According to a status report filed Nov. 15, “FDA proposes to work through the list of documents that Plaintiff requested FDA prioritize for production in order of priority at a rate of 500 pages per month,” since this rate is “consistent with processing schedules entered by courts across the country in FOIA cases.”
WATCH:ELON MUSK TALKS ABOUT THE FUTURE OF SELF DRIVING CARS
The plaintiffs, a group of 30 scientists, academics, and professors under the name Public Health and Medical Professionals for Transparency (referred to as PROMPT in the report), filed the lawsuit on August 27. Since the agency did not publish a single document since this group’s open records request, made nearly three months ago, they asked the court to give the FDA until March 3, 2022 to perform the records request.
WATCH ALAN DERSHOWITZ: "THERE IS NO CRIME IN MANHATTAN"
The agency accountable for approving a brand new pharmaceutical they knew would be instantly mandated for millions of Americans complained that the plaintiffs were requesting they “process and produce” over 80,000 pages a month, insisting they do not have the personnel to redact sensitive information from the records at that rate.
PUTIN'S LATEST POWER MOVE: RUSSIA DISPLAYS "WAR WINS" IN EYE-OPENING EXHIBITION
The PROMPT has claimed that since it took the FDA just 108 days to conduct what it insists is a “rigorous” examination of the documents to decide whether Pfizer’s product was safe to approve, it has to be able to release documents to the public in a similar timeframe.
HOW DEMOCRATS' ANTI-ISRAEL PROTESTS ARE TURNING INTO THEIR WORST NIGHTMARE
Though the agency maintains this argument is “specious,” as its information specialists conduct an “entirely different” kind of review when deciding what information must be kept confidential.
The FDA cited an unrelated decision by the D.C. Circuit Court, which said that “another agency’s policy of processing 500 pages per request per month… ‘s serves to promote efficient responses to a larger number of requesters,’” and that enabling this plaintiff to similarly “jump to the head of the FOIA processing line would upset the agency’s processes and be detrimental to the other expedited requesters.”
Discover alternative ideas that will make you think
Engage in mind bending debate
Earn points, rise in rank, have fun
